RBC Capital Rates ICON Public (ICLR) buy, $185 Price Target

RBC Capital upgraded ICON PLC to a buy rating with a $185 price target, a 8.91% upside from the current price.

By EarningsIQ Research Desk · Published Jun 25, 2026, 12:01 PM EDT · Updated Jun 29, 2026, 1:01 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

RBC Capital rated ICON Public Limited Company ($ICLR) "buy" with a $185 price target on June 25, 2026.

Since the rating, $ICLR is up 7.5% after 1 week, up 4.9% after 1 month and up 5.7% to date (from the $160.96 close on Jun 25, 2026).

ICLR ICON Public Limited Company

$170.18 -9.80% year to date

Daily close · Oct 16, 2026

Key Points

RBC Capital upgraded ICON PLC (ICLR) to a buy rating on June 25, 2026, with a new price target of $185.
RBC Capital's $185 price target implies 8.91% upside from ICON Public Limited Company's ($ICLR) current $169.86 share price.
Shares of ICON PLC traded at $158.17 on Thursday, with a market cap of about $10.78 billion and a 52-week range of $66.57 to $211.00.
Peers like Artisan Partners and Wellington Management have also increased their holdings in ICON PLC recently.

Get $ICLR trade alerts by text

We text you when insiders, Congress or big funds trade $ICLR. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated ICON Public Limited Company alert may contain errors. Disclosures

ICON Public Limited Company (NasdaqGS: ICLR) received an upgrade from RBC Capital on June 25, 2026. Analyst Ryan Halsted raised the rating to a 'buy' and set a new price target of $185. As of Thursday, the stock was trading at $158.17.

Analyst rating track record

RBC Capital vs. the S&P 500

YTD return +5.59% hypothetical

All-time return +9.32% S&P 500 +28.91%

vs. S&P 500 -19.59% behind the index

Hypothetical returns from RBC Capital's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in ICON PLC

Artisan Partners Limited Partnership increased its holdings in ICON PLC by 1,404,968 shares, reaching a total of 8,278,945 shares valued at approximately $916.1 million, marking a 20.4% increase. Wellington Management Group LLP also boosted its position by 1,562,287 shares, ending with 5,913,037 shares worth about $654.3 million, a 35.9% increase. Harris Associates L.P. made a significant move by adding 1,841,151 shares, raising its total to 4,351,317 shares valued at $481.5 million, a 73.3% increase. FMR LLC saw a 34.7% increase in its holdings, adding 1,076,111 shares to reach 4,174,006 shares worth around $461.9 million. Meanwhile, Invesco Ltd. increased its stake by 121,973 shares to hold 3,878,869 shares valued at $429.2 million, a 3.2% rise.

ICON Public Limited Company Stock Up 3.5%

On Thursday, ICON PLC's shares traded at $158.17. The company, with a market cap of approximately $10.78 billion, has a P/E ratio of 48.36 and a forward P/E of 12.03. Its beta is 1.271, indicating moderate volatility. The stock's 52-week range spans from $66.57 to $211.00, with a 50-day moving average of $124.49 and a 200-day moving average of $149.71. ICON's current ratio is 1.096, and its quick ratio is 1.063, showing a solid liquidity position.

12-month forecast

$ICLR price target

ICON Public Limited Company daily closes and this analyst's $185 target. Not advice.

Recent Earnings

ICON PLC reported revenue of approximately $8.25 billion, with a revenue growth rate of 12.4%. The company's net margin stands at 2.78%, and it reported an EPS of $2.91. Return on equity is 2.46%. The next earnings report is expected on June 23, 2026.

Insider Buying and Selling at ICON Public Limited Company

On May 14, 2026, insider transactions at ICON PLC included both purchases and sales. Dr. John Climax bought and sold 5,005 shares, while Ronan Martin Murphy also executed similar transactions with 5,005 shares. Eugene Pacelli McCague bought and sold 3,255 shares on the same day.

Analysts Set New Price Targets

On June 25, 2026, several analysts issued new ratings and price targets for ICON PLC. Barclays maintained a 'hold' rating with a $175 target, while RBC Capital upgraded to a 'buy' with a $185 target. TD Cowen maintained a 'buy' rating, setting a target of $197. JP Morgan maintained a 'hold' with a $155 target, and Evercore ISI Group maintained a 'buy' with a $180 target. B of A Securities maintained a 'sell' with a $150 target, and Baird maintained a 'buy' with a $186 target. The consensus rating remains a 'buy', with a mean target price of $154.19 from 16 analysts.

About ICON Public Limited Company

ICON Public Limited Company is a leading clinical research organization headquartered in Dublin, Ireland. The company provides a range of outsourced development and commercialization services, including clinical trials and laboratory services, to pharmaceutical, biotechnology, and medical device industries worldwide. Led by CEO Barry Balfe, ICON employs approximately 40,100 people and operates in various regions, including Europe and the United States.

Bottom Line

RBC Capital's upgrade of ICON PLC to a 'buy' with a $185 price target reflects positive sentiment on the stock. Investors are closely watching ICON due to its strategic role in the healthcare sector and its recent institutional interest. The upgrade is based on analysis as of the rating date and may not reflect the latest market conditions.